EUVIMEDEUVIMED entdecken
Crossref

Impact of oncology review meetings on second opinions for patients with gastrointestinal cancer

Marc Nourrit, Géraldine M Camilleri, Anne-Claire Couderc, Audrey Verchain, Kamilia Bouatay, Marine Valéry, Cristina Smolenschi, Antoine Hollebecque, Thomas Pudlarz, Alexandre Megherbi, Laura Diebakate, Matthieu Delaye und 4 weitere

Supportive Care in Cancer · 2025

DOI: 10.1007/s00520-025-09922-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Supportive Care in Cancer, 2025. Verfasst von Marc Nourrit und 15 weiteren Autor:innen. Beteiligte Einrichtung: Département de Médecine, Gustave Roussy, 114 Rue Edouard Vaillant, 94800, Villejuif, France. Hauptthemen laut MEDLINE: Gastrointestinal Neoplasms, Referral and Consultation, Medical Oncology. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Second opinions are increasingly sought by patients, particularly in complex and life-altering conditions such as gastrointestinal (GI) cancers, to ensure confidence in their diagnosis and treatment plans or to seek therapeutic trials. METHODS: This retrospective study analyzed second-opinion requests handled by the GI oncology team in our institution between January and March 2024, examining the types of questions raised, patient characteristics, and their impact on clinical decision-making. RESULTS: Of 261 eligible patients, 259 were included in this analysis. Most patients had metastatic disease (86%), and 51% had received at least two lines of prior treatment. Requests were predominantly submitted by oncologists (63%), with a significant proportion (41%) coming from outside academic centers. General practitioners (GPs) accounted for 37% of the submissions, often with incomplete records (86% completeness vs. 99% for oncologists; p < 0.01). The median age at diagnosis was 60 years, with younger patients being more frequently referred by oncologists (57.0 vs. 62.5 years, p < 0.001). The most common diagnoses were pancreatic (29%) and colorectal (27%) cancers. Second-opinion requests focused on therapeutic management (73%) and access to clinical trials (60%). Therapeutic decisions were in line with the standard of care in 93% of the cases, while 15% received alternative recommendations, such as intrahepatic arterial infusion or targeted therapies. However, participation in therapeutic trials (1.2%) and molecular screening (2.7%) was seldom offered to patients, highlighting the need for better tools to access trials. Importantly, palliative care decisions were upheld in 95% of the specific requests. CONCLUSION: This study demonstrates the potential value of structured second-opinion pathways in ensuring adherence to evidence-based care and addressing patient concerns. However, improving GP support, reducing referral delays, and optimizing access to trials remain critical for improving outcomes in patients with advanced GI cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal NeoplasmsReferral and ConsultationMedical OncologyHumansRetrospective StudiesMiddle AgedFemaleMaleAgedAdultOncologistsClinical Decision-MakingAged, 80 and overGeneral Practitioners

Stichwörter der Autor:innen

Gastrointestinal cancersSecond opinionSystemic treatmentsTherapeutic trials

Autor:innen und Institutionen

  • Département de Médecine, Gustave Roussy, 114 Rue Edouard Vaillant, 94800, Villejuif, France.
  • Département D'oncologie Médicale, CHU de La Réunion, 97410, Saint Pierre, France.
  • Université Paris Saclay, 91400, Orsay, France.
  • Gustave Roussy, INSERM U1279, 94800, Villejuif, France.
  • Département de Médecine, Gustave Roussy, 114 Rue Edouard Vaillant, 94800, Villejuif, France. Alice.boileve@gustaveroussy.fr.
  • Université Paris Saclay, 91400, Orsay, France. Alice.boileve@gustaveroussy.fr.

Zitieren

APA

Nourrit, M., Camilleri, G. M., Couderc, A. C., Verchain, A., Bouatay, K., Valéry, M., Smolenschi, C., Hollebecque, A., Pudlarz, T., Megherbi, A., Diebakate, L., Delaye, M., Khettab, M., Boige, V., Ducreux, M., & Boilève, A. (2025). Impact of oncology review meetings on second opinions for patients with gastrointestinal cancer. Supportive Care in Cancer. https://doi.org/10.1007/s00520-025-09922-8

Vancouver

Nourrit M, Camilleri GM, Couderc AC, Verchain A, Bouatay K, Valéry M, et al. Impact of oncology review meetings on second opinions for patients with gastrointestinal cancer. Supportive Care in Cancer. 2025. doi:10.1007/s00520-025-09922-8

BibTeX
@article{Nourrit2025,
  author = {Nourrit, Marc and Camilleri, Géraldine M and Couderc, Anne-Claire and Verchain, Audrey and Bouatay, Kamilia and Valéry, Marine and Smolenschi, Cristina and Hollebecque, Antoine and Pudlarz, Thomas and Megherbi, Alexandre and Diebakate, Laura and Delaye, Matthieu and Khettab, Mohamed and Boige, Valérie and Ducreux, Michel and Boilève, Alice},
  title = {Impact of oncology review meetings on second opinions for patients with gastrointestinal cancer},
  journal = {Supportive Care in Cancer},
  year = {2025},
  doi = {10.1007/s00520-025-09922-8}
}
Kostenlos starten →